Bipolar Disorder Trial, Recruiting NCT06665984 Sponsor: The University of Texas Health Science Center, Houston Condition: Bipolar Disorder
Back to Bipolar Disorder

Bipolar Disorder Trial, Recruiting

NCT06665984
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For young people with bipolar disorder:

  • People whose bipolar disorder has been diagnosed according to standard diagnostic guidelines (DSM-V), covering bipolar type I, type II, or a related form, confirmed through a structured interview
  • People currently experiencing any mood state are still eligible to be considered

For children or young people who have a parent with bipolar disorder:

  • People with at least one parent who has been diagnosed with bipolar type I, type II, or a related form, confirmed through a structured interview

For healthy comparison participants:

  • People with no personal psychiatric diagnosis and no close family history of bipolar disorder, psychotic disorders, schizophrenia, or schizoaffective disorder

Who may not be able to join:

For young people with bipolar disorder or those with a bipolar parent:

  • People who have been diagnosed with Autism Spectrum Disorder (ASD)
  • People who have an intellectual or developmental disability
  • People who have a serious neurological condition that affects thinking or cognition, such as epilepsy, traumatic brain injury, or tuberous sclerosis
  • People who have a diagnosis of schizophrenia
  • People with a serious or uncontrolled medical condition, as determined by the trial investigators
  • Children of bipolar parents whose parents have a history of any brain disease (such as seizures, stroke, meningitis, encephalitis, dementia, or other degenerative brain conditions), or whose parents have a history of intellectual disability

For healthy comparison participants:

  • People with any psychiatric diagnosis
  • People with a close family member (parent or sibling) who has had bipolar disorder, a psychotic disorder, schizophrenia, or schizoaffective disorder
  • People with a close family member who has had a neurological condition
  • People with an intellectual disability
  • People with a serious neurological condition affecting cognition, such as epilepsy, traumatic brain injury, or tuberous sclerosis
  • People with schizophrenia
  • People with a serious or uncontrolled medical condition, as determined by the trial investigators

For ongoing annual follow-up visits (all groups):

  • People with ASD, an intellectual developmental disorder, a serious neurological condition affecting cognition, schizophrenia, or an uncontrolled medical condition may not be eligible to continue in annual follow-up visits (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jair C Soares, M.D. PhD, The University of Texas Health Science Center, Houston

Phone: (713) 486-6663

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
6 December 2022
Est. completion
6 December 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Positive Identification of Bipolar Disorder as Assessed by Mini-International Neuropsychiatric Interview for Children and Adolescents (MINI Kid 7.2) (child)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov